Article info

Download PDFPDF

OP0217 Ustekinumab is superior to TNF inhibitor treatment in resolving enthesitis in PSA patients with active enthesitis- results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study
Free

Authors

Citation

Araujo E, Englbrecht M, Hoepken S, et al
OP0217 Ustekinumab is superior to TNF inhibitor treatment in resolving enthesitis in PSA patients with active enthesitis- results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study

Publication history

  • First published June 15, 2017.
Online issue publication 
June 15, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.